Antimicrobial Activity of Some Medicinal Herbs to the Treatment of Cutaneous and Mucocutaneous Infections: Preliminary Research

(1) Background: Superficial, including cutaneous and mucocutaneous infections are a current public health problem with universal distribution. One of the main concerns, in the present/future, is fungal/bacterial infections by resistant microorganisms. This study aimed to verify if decoctions of copt...

Full description

Saved in:
Bibliographic Details
Published inMicroorganisms (Basel) Vol. 11; no. 2; p. 272
Main Authors Noites, Alexandra, Borges, Iara, Araújo, Bruno, da Silva, Joaquim C G Esteves, de Oliveira, Natália M, Machado, Jorge, Pinto, Eugénia
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 20.01.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:(1) Background: Superficial, including cutaneous and mucocutaneous infections are a current public health problem with universal distribution. One of the main concerns, in the present/future, is fungal/bacterial infections by resistant microorganisms. This study aimed to verify if decoctions of coptidis ( , Ranunculaceae family), neem ( , Meliaceae family), and their essential oils (EOs), as well as the EO of manuka ( , Myrtaceae family) have antimicrobial activity against prevalent species of microorganisms responsible for superficial infections. (2) Methods: The antimicrobial activity was determined by the minimum inhibitory concentration (MIC), using broth microdilution method, and minimum lethal concentration (MLC) was determined from subculture of MIC plates. (3) Results: EO and decoction demonstrated some antifungal action against the yeasts and dermatophytes tested. Greatest bactericidal effect against and some action against was observed. For only EO proved activity against dermatophytes and . EO showed the broadest antimicrobial spectrum with activity against bacteria, yeasts, and dermatophytes showing greater activity against and . (4) Conclusions: (EO/decoction), EOs of and proved in vitro efficacy against fungal, bacterial, or mixed agents of superficial infections, either by sensitive or resistant strains.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2076-2607
2076-2607
DOI:10.3390/microorganisms11020272